Dr. Krishnamohan R. Basarakodu, MD
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Years since graduation
- 29
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 290
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
MO license 2007001544
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Southeast Health Medical Center Dothan, AL
- Flowers Hospital Dothan, AL
Medical groups
- Houston County Healthcare Authority (253 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 290
- Services billed
- 1,141
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 455 | 116 |
| Established patient office or other outpatient visit, 30-39 minutes | 380 | 174 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 222 | 63 |
| Established patient office or other outpatient visit, 20-29 minutes | 79 | 57 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 58 | 32 |
| New patient office or other outpatient visit, 60-74 minutes | 55 | 55 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 51 | 47 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 27 | 27 |
| New patient office or other outpatient visit, 45-59 minutes | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Anastrozole Other prescribers in Dothan, AL | 268 |
| Prochlorperazine Maleate Other prescribers in Dothan, AL | 127 |
| Gabapentin Other prescribers in Dothan, AL | 94 |
| Prednisone Other prescribers in Dothan, AL | 81 |
| Oxycodone Hcl Other prescribers in Dothan, AL | 71 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Dothan, AL | 69 |
| Morphine Sulfate Er (morphine sulfate) Other prescribers in Dothan, AL | 57 |
| Dexamethasone Other prescribers in Dothan, AL | 52 |
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in Dothan, AL | 48 |
| Hydroxyurea Other prescribers in Dothan, AL | 47 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 32 companies reported 107 payments worth $2,374 in total to this clinician.
| Merck Sharp & Dohme LLC | $223 |
|---|---|
| Novartis Pharmaceuticals Corporation | $179 |
| Pfizer Inc. | $135 |
| AstraZeneca Pharmaceuticals LP | $132 |
| Ipsen Biopharmaceuticals, Inc | $127 |
| E.r. Squibb & Sons, L.l.c. | $120 |
| Janssen Biotech, Inc. | $110 |
| Array Biopharma Inc | $108 |
| Food and Beverage | $2,274 |
|---|---|
| Education | $99.95 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc Jan 21, 2025 | Education in-kind | $99.95 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.